度洛西汀致低钠血症1例。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI:10.4140/TCP.n.2018.446

Daniel Hu, Sarah Wurster

{"title":"度洛西汀致低钠血症1例。","authors":"Daniel Hu, Sarah Wurster","doi":"10.4140/TCP.n.2018.446","DOIUrl":null,"url":null,"abstract":"Purpose: There are a limited number of case reports in the literature which describe hyponatremia/syndrome of inappropriate antidiuretic hormone (SIADH) induced by duloxetine.Summary: This case report adds to the literature by describing a patient who developed hyponatremia/SIADH after two doses of duloxetine.Conclusion: Hyponatremia/SIADH can develop rapidly after initiation of duloxetine. Clinicians should be aware of the potential for this adverse drug reaction, particularly in elderly females.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":"33 8","pages":"446-449"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2018.446","citationCount":"4","resultStr":"{\"title\":\"Hyponatremia Induced by Duloxetine: A Case Report.\",\"authors\":\"Daniel Hu, Sarah Wurster\",\"doi\":\"10.4140/TCP.n.2018.446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: There are a limited number of case reports in the literature which describe hyponatremia/syndrome of inappropriate antidiuretic hormone (SIADH) induced by duloxetine.Summary: This case report adds to the literature by describing a patient who developed hyponatremia/SIADH after two doses of duloxetine.Conclusion: Hyponatremia/SIADH can develop rapidly after initiation of duloxetine. Clinicians should be aware of the potential for this adverse drug reaction, particularly in elderly females.\",\"PeriodicalId\":45985,\"journal\":{\"name\":\"CONSULTANT PHARMACIST\",\"volume\":\"33 8\",\"pages\":\"446-449\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4140/TCP.n.2018.446\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CONSULTANT PHARMACIST\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4140/TCP.n.2018.446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CONSULTANT PHARMACIST","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2018.446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 4

摘要

目的:文献中关于度洛西汀诱导的低钠血症/不适当抗利尿激素综合征(SIADH)的病例报道数量有限。摘要:本病例报告通过描述两剂度洛西汀后发生低钠血症/SIADH的患者，增加了文献。结论:度洛西汀开始使用后，低钠血症/SIADH可迅速发展。临床医生应该意识到这种药物不良反应的可能性，特别是在老年女性中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hyponatremia Induced by Duloxetine: A Case Report.

Purpose: There are a limited number of case reports in the literature which describe hyponatremia/syndrome of inappropriate antidiuretic hormone (SIADH) induced by duloxetine.

Summary: This case report adds to the literature by describing a patient who developed hyponatremia/SIADH after two doses of duloxetine.

Conclusion: Hyponatremia/SIADH can develop rapidly after initiation of duloxetine. Clinicians should be aware of the potential for this adverse drug reaction, particularly in elderly females.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

CONSULTANT PHARMACIST PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Vision ... The Society"s long-term desire, aspiration, and core purpose. The vision of the American Society of Consultant Pharmacists is optimal medication management and improved health outcomes for all older persons. Mission ... The Society"s strategic position, focus, and reason for being. The American Society of Consultant Pharmacists empowers pharmacists to enhance quality of care for all older persons through the appropriate use of medication and the promotion of healthy aging.